Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Top Cited Papers
Open Access
- 20 October 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 64 (2) , 134-140
Abstract
Candida auris, a multidrug-resistant yeast that causes invasive infections, was first described in 2009 in Japan and has since been reported from several countries. To understand the global emergence and epidemiology of C. auris, we obtained isolates from 54 patients with C. auris infection from Pakistan, India, South Africa, and Venezuela during 2012–2015 and the type specimen from Japan. Patient information was available for 41 of the isolates. We conducted antifungal susceptibility testing and whole-genome sequencing (WGS). Available clinical information revealed that 41% of patients had diabetes mellitus, 51% had undergone recent surgery, 73% had a central venous catheter, and 41% were receiving systemic antifungal therapy when C. auris was isolated. The median time from admission to infection was 19 days (interquartile range, 9–36 days), 61% of patients had bloodstream infection, and 59% died. Using stringent break points, 93% of isolates were resistant to fluconazole, 35% to amphotericin B, and 7% to echinocandins; 41% were resistant to 2 antifungal classes and 4% were resistant to 3 classes. WGS demonstrated that isolates were grouped into unique clades by geographic region. Clades were separated by thousands of single-nucleotide polymorphisms, but within each clade isolates were clonal. Different mutations in ERG11 were associated with azole resistance in each geographic clade. C. auris is an emerging healthcare-associated pathogen associated with high mortality. Treatment options are limited, due to antifungal resistance. WGS analysis suggests nearly simultaneous, and recent, independent emergence of different clonal populations on 3 continents. Risk factors and transmission mechanisms need to be elucidated to guide control measures.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (U19AI110818)
- United States Agency for International Development (4-338/PAK-US/HEC/2010/932)
This publication has 32 references indexed in Scilit:
- Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analysesEmerging Microbes & Infections, 2016
- Candida aurisCandidemia in Kuwait, 2014Emerging Infectious Diseases, 2015
- Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest MethodJournal of Clinical Microbiology, 2015
- Incidence, characteristics and outcome of ICU-acquired candidemia in IndiaIntensive Care Medicine, 2014
- Candida auris–Associated Candidemia, South AfricaEmerging Infectious Diseases, 2014
- Multidrug-resistant endemic clonal strain of Candida auris in IndiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2013
- New Clonal Strain ofCandida auris, Delhi, IndiaEmerging Infectious Diseases, 2013
- First Three Reported Cases of Nosocomial Fungemia Caused by Candida aurisJournal of Clinical Microbiology, 2011
- Candida haemuloniiand Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical FeaturesClinical Infectious Diseases, 2009
- Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospitalMicrobiology and Immunology, 2009